Abiopharma

🔍 Urvan Steven F. (Executive)

Company: Outdoor Holding Co (POWW)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 15,000 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: false | shares_owned_after: 150,509.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,448 shares of Common Stock at $2.24 per share (Direct)
  Date: 2026-08-17 | Code: F | equity_swap_involved: false | shares_owned_after: 146,061.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: J | equity_swap_involved: false | shares_owned_after: 17,222,857.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Reflects the grant of 15,000 shares of common stock that members of the issuer's Board of Directors (the "Board") receive quarterly as part of their annual compensation for Board service. The reporting person pays no consideration for these shares.
• F2: Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations incurred by the reporting person as a result of the shares received on August 17, 2026.
• F3: These shares are held by UFO LLC ("UFO"). UFO is a single-member limited liability company whose sole member is the 50 X 50 Trust, a Nevada irrevocable domestic asset protection trust of which Mr. Urvan is the grantor, investment trust adviser and a discretionary beneficiary. Mr. Urvan serves as a manager of UFO and, in that capacity, has sole voting and dispositive power over the shares held by UFO. Mr. Urvan may be deemed to beneficially own the securities held by UFO and disclaims beneficial ownership except to the extent of his pecuniary interest therein.This line item is being voluntarily re-reported solely to reflect the reporting person's total beneficial holdings following the direct transaction(s) reported on Lines 1 and 2 of this table, and does not represent a new transaction or any change in indirect ownership.